Bayer Consumer Group 70% Growth Driven By Roche OTC Buy
This article was originally published in The Tan Sheet
Executive Summary
Bayer posted "exceptionally strong" third-quarter gains in its consumer care division with sales increasing 70% to $695.1 mil. (€1 = $1.18), primarily due to products newly acquired in the Roche purchase